Delivery Order SPE2DB24D1205-SPE2DB24FCSRQ
Award Date
7/11/24
Potential Completion Date
8/1/24
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VYEPTI 100 MG/ML VIALML. The award, valued at $42,700.40, is a firm fixed-price contract with an ultimate completion date of August 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for delivering a comprehensive range of medical commodities to support...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of VYEPTI 100 MG/ML VIALML, a medical product, with a ceiling value of $8,100.26 and a period of performance through July 8, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,287.20 firm fixed-price contract is for the supply of VYEPTI 100 MG/ML VIALML, a medication, with a performance period ending on February 21, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply VYEPTI 100 MG/ML VIAL medication. The contract has a ceiling value of $3,202.53 and a period of performance through August 22, 2024. It is a Firm Fixed Price, Delivery Order contract type with no set-aside designation. Amerisourcebergen is the prime contractor providing these pharmaceutical products to support military treatment...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. The award does not have a set-aside designation. The potential value of the delivery order is $14,945.14, with a completion date of March 27, 2024. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $6,405.06 firm fixed price delivery order is for VYEPTI 100 MG/ML VIALML, a specialty pharmaceutical product. The contract has a completion date of March 7, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,628.72 firm fixed price contract is for the supply of VYEPTI 100 MG/ML VIALML, with a performance period ending on July 14, 2025. Amerisourcebergen Drug Corp is not a small business, as the contract is not set aside. The company holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
The federal contract award is for the pharmaceutical product VYEPTI 100 MG/ML VIALML, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,313.20 firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on December 12, 2024, with a planned completion date of January 6, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of Vyepti 100 mg/ml vials, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,471.54 and a performance period through July 3, 2025. The contract is not set aside and was awarded on June 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
This federal contract award is for the delivery of VYEPTI 100 MG/ML VIALML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,471.54 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 14, 2025 and was awarded on February 21, 2025. There is no set-aside designation indicated for this contract. Amerisourcebergen holds a...